Lesaffre Yeast Corporation has acquired ABM to join as part of Agrauxine USA
Lesaffre announces the acquisition of ABM, Advanced Biological Marketing, a company specializing in the development of bio nutrition products for field crops in the American Midwest. With this acquisition, Agrauxine by Lesaffre, the business unit of Lesaffre specialized in crop protection, is strengthening its presence in the United States.
Development in the World’s Largest Biosolutions Market
As a global player in the field of fermentation and microorganisms, Lesaffre has been present in the United States since the 1980s and has expanded its manufacturing capabilities since then. Lesaffre currently employs over 500 people in its various US manufacturing sites and marketing centers. Today the company announces the acquisition of ABM, a company based in Van Wert (Ohio), specializing in seed treatment with bio nutrition products. ABM’s teams will join those of Agrauxine by Lesaffre, Lesaffre’s business unit dedicated to crop protection. Agrauxine by Lesaffre has been developing biosourced solutions for plant nutrition and health for more than 15 years. Agrauxine by Lesaffre wishes to accelerate its development in the United States with this acquisition. With ABM integration, the business unit now counts nearly 40 employees in the country.
Complementary Expertise Allowing for Synergies
This acquisition represents a good step in the development of Agrauxine by Lesaffre, and allows it to achieve strong complementarities in terms of access to markets as well as in terms of biocontrol and biostimulation product ranges. Agrauxine will pursue ABM projects, including two new biocontrol technologies. These strategic technologies will be commercialized in the US market in the next years.